SPP1-mediated microglial synaptic engulfment assay

Exploratory Score: 0.950 Price: $0.50 Alzheimer's disease AD mouse models with amyloid-β oligomers Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting SPP1 in AD mouse models with amyloid-β oligomers. Primary outcome: Microglial synaptic engulfment and phagocytic marker expression

Description

Functional assays examining the role of SPP1 in promoting microglial engulfment of synapses in the presence of amyloid-β oligomers. The experiment tested whether perivascular SPP1 is required for microglia to engulf synapses and upregulate phagocytic markers including C1qa, Grn, and Ctsb. This involved measuring microglial phagocytic activity and marker expression in response to SPP1 signaling.

TARGET GENE
SPP1
MODEL SYSTEM
AD mouse models with amyloid-β oligomers
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
microglial phagocytosis and complement activation
SOURCE
extracted_from_pmid_36747024
PRIMARY OUTCOME
Microglial synaptic engulfment and phagocytic marker expression

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.950 composite

📖 Wiki Pages

SPP1 GenegeneTREM2 Variants in Alzheimer's DiseasediseaseMicrogliaentityPSEN2 Mutations in Alzheimer's DiseasediseaseSporadic vs Familial Alzheimer's Disease: ComprehediseaseMicrogliacellAgitation in Alzheimer's DiseasediseaseAlzheimer's DiseasediseaseAlzheimer's DiseasediseaseAlzheimer's Disease Genetic VariantsdiseaseAlzheimer's Disease vs Parkinson's Disease ComparidiseaseAPP Mutations in Alzheimer's DiseasediseaseDLB, Parkinson's Disease, and Alzheimer's Disease:diseaseEarly-Onset Alzheimer's Disease (EOAD)diseaseInvestment Landscape: Alzheimer's Diseasedisease

Protocol

Phase 1: Primary Cell Culture and SPP1 Manipulation — Week 1-2
Isolate primary microglia from P0-P2 C57BL/6J pups using magnetic-activated cell sorting (MACS) with CD11b+ microbeads (Miltenyi Biotec, 130-049-601). Maintain in DMEM/F12 with 10% FBS, 1% penicillin/streptomycin, and 10 ng/mL M-CSF (R&D Systems, 416-ML-010). Transfect microglia (n=6 wells per condition) with SPP1 siRNA (50 nM, Dharmacon L-040777-01-0005) or scrambled control using Lipofectamine RNAiMAX (Thermo Fisher, 13778150). Confirm 70-80% knockdown by qRT-PCR after 48h. Prepare amyloid-β1-42 oligomers (Anaspec, AS-24224) at 5 μM by dissolving in DMSO, diluting in phenol-red-free F12, and incubating at 4°C for 24h.

...

Expected Outcomes

  • 1. Primary: SPP1 knockdown will reduce microglial synaptic engulfment by >40% compared to scrambled control (Cohen's d > 0.8, p < 0.01)
  • 2. Secondary: C1qa mRNA expression will be decreased by 50-70% in SPP1 siRNA-treated microglia exposed to Aβ oligomers
  • 3. Tertiary: Grn and Ctsb mRNA levels will show 30-50% reduction following SPP1 knockdown
  • 4. Quaternary: CD68 protein expression (phagocytic marker) will be 35-60% lower in SPP1-deficient microglia
  • 5. Negative control: Vehicle-treated synaptosomes will show minimal pHrodo signal uptake (<10% of Aβ-treated)
  • 6.

...

Success Criteria

  • • Statistical significance: p < 0.05 for primary outcomes with effect size Cohen's d > 0.6
  • • Cell viability: >85% viable microglia throughout experiment (trypan blue exclusion)
  • • Knockdown efficiency: >70% SPP1 mRNA reduction confirmed by qRT-PCR
  • • Data quality: RNA integrity number (RIN) >7.0 for all qRT-PCR samples
  • • Reproducibility: Primary findings replicated in ≥3 independent microglial preparations
  • • Technical validation: Cytochalasin D treatment reduces phagocytosis by >80%
  • • Sample completion: >90% of planned samples successfully analyzed for primary endpoints

Related Hypotheses (9)

Temporal SPP1 Inhibition During Critical Windows0.728
TREM2-mediated microglial tau clearance enhancement0.594
IGFBPL1-Mediated Homeostatic Restoration0.584
VCP-Mediated Autophagy Enhancement0.571
Perinatal Hypoxia-Primed Microglia Targeting0.548

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.